Paul Kelly Marcom, MD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 10 Bryan Searle Drive, Room 461 Seeley G. Mudd Building, Durham, NC 27710
Phone (919) 684-3877
Email address marco001@mc.duke.edu

Basic Science:
-Germline and somatic genetic changes in breast cancer.

Translational:
-Identification and management of individuals and families with hereditary cancer risk.
-Communication of cancer risk information to individuals and families.
-Breast cancer prevention.
-Optimizing management of early breast cancer.
-Treatment of metastatic breast cancer

Clinically, Dr. Marcom works as a medical oncologist in the multidisciplinary breast cancer clinic. He participates in clinical trials investigating new chemotherapeutic and biologic treatments. 

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 1992 - 1995
  • Medical Resident, Medicine, Duke University, 1989 - 1992
  • M.D., Baylor University, 1989

Grants

Publications

Tung, Nadine, Banu Arun, Michele R. Hacker, Erin Hofstatter, Deborah L. Toppmeyer, Steven J. Isakoff, Virginia Borges, et al. “TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).” J Clin Oncol 38, no. 14 (May 10, 2020): 1539–48. https://doi.org/10.1200/JCO.19.03292.

PMID
32097092
Full Text

Gradishar, William J., Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Sarah L. Blair, et al. “Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 4 (April 2020): 452–78. https://doi.org/10.6004/jnccn.2020.0016.

PMID
32259783
Full Text

Strickler, John H., Christel N. Rushing, Donna Niedzwiecki, Abigail McLeod, Ivy Altomare, Hope E. Uronis, S David Hsu, et al. “A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.” Bmc Cancer 19, no. 1 (November 1, 2019): 1032. https://doi.org/10.1186/s12885-019-6234-8.

PMID
31675952
Full Text

Kikuchi, Robin, Gloria Broadwater, Rebecca Shelby, Jessica Robertson, Leah L. Zullig, Bailey Maloney, Claudia Meyer, et al. “Detecting geriatric needs in older patients with breast cancer through use of a brief geriatric screening tool.” J Geriatr Oncol 10, no. 6 (November 2019): 968–72. https://doi.org/10.1016/j.jgo.2019.04.010.

PMID
31005647
Full Text

Fayanju, Oluwadamilola M., Karine Yenokyan, Yi Ren, Benjamin A. Goldstein, Ilona Stashko, Steve Power, Madeline J. Thornton, P Kelly Marcom, and E Shelley Hwang. “The effect of treatment on patient-reported distress after breast cancer diagnosis.” Cancer 125, no. 17 (September 1, 2019): 3040–49. https://doi.org/10.1002/cncr.32174.

PMID
31120575
Full Text

Tolaney, Sara M., Hao Guo, Sonia Pernas, William T. Barry, Deborah A. Dillon, Lauren Ritterhouse, Bryan P. Schneider, et al. “Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.” J Clin Oncol 37, no. 22 (August 1, 2019): 1868–75. https://doi.org/10.1200/JCO.19.00066.

PMID
30939096
Full Text

Dorfman, Caroline S., Sarah S. Arthur, Gretchen G. Kimmick, Kelly W. Westbrook, Paul Kelly Marcom, Cheyenne Corbett, Sara N. Edmond, and Rebecca A. Shelby. “Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.” Menopause 26, no. 8 (August 2019): 823–32. https://doi.org/10.1097/GME.0000000000001337.

PMID
30994574
Full Text

Bellon, Jennifer R., Hao Guo, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P Kelly Marcom, et al. “Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).” Breast Cancer Res Treat 176, no. 2 (July 2019): 303–10. https://doi.org/10.1007/s10549-019-05238-4.

PMID
31004299
Full Text

Mazurowski, Maciej A., Ashirbani Saha, Michael R. Harowicz, Elizabeth Hope Cain, Jeffrey R. Marks, and P Kelly Marcom. “Association of distant recurrence-free survival with algorithmically extracted MRI characteristics in breast cancer.” J Magn Reson Imaging 49, no. 7 (June 2019): e231–40. https://doi.org/10.1002/jmri.26648.

PMID
30672045
Full Text

Mayer, Erica L., Vandana Gupta Abramson, Rachel Catherine Jankowitz, Carla Isadora Falkson, Paul Kelly Marcom, Tiffany A. Traina, Lisa A. Carey, et al. “TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC—Evaluating the homologous recombination deficiency (HRD) biomarker.” In Journal of Clinical Oncology, 37:507–507. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.507.

Full Text

Pages